Diversified Trust CO Cytom X Therapeutics, Inc. Transaction History

Diversified Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Jan 13, 2022	SELL	$4.32 - $6.43 $45,714 - $68,042	-10,582 Closed	0 $0
Q2 2021 Jul 20, 2021	SELL	$6.33 - $9.91 $35,492 - $55,565	-5,607 Reduced 34.63%	10,582 $67,000
Q1 2021 May 10, 2021	BUY	$6.6 - $9.0 $106,847 - $145,701	16,189 New	16,189 $125,000
Q4 2020 Jan 08, 2021	SELL	$6.47 - $7.9 $88,321 - $107,842	-13,651 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$6.55 - $8.83 $19,984 - $26,940	3,051 Added 28.78%	13,651 $91,000
Q2 2020 Jul 07, 2020	BUY	$7.4 - $14.64 $78,440 - $155,184	10,600 New	10,600 $88,000

49.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.